JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, P.
Right arrow Articles by Olinsky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, P.
Right arrow Articles by Olinsky, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2003, p. 5741, Vol. 41, No. 12
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.12.5741.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Pseudomonas Cross-Infection from Cystic Fibrosis Patients to Non-Cystic Fibrosis Patients: Implications for Inpatient Care of Respiratory Patients

P. Robinson,1* R. Carzino,1 D. Armstrong,2 and A. Olinsky1

Cystic Fibrosis Unit, Department of Respiratory Medicine, Royal Children's Hospital,1 Department of Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Australia2

Received 14 July 2003/ Returned for modification 25 July 2003/ Accepted 27 August 2003

A 14-year-old boy with bronchiectasis secondary to chronic aspiration developed multiresistant Pseudomonas aeruginosa lower respiratory disease following several inpatient periods where accommodation and physiotherapy services were shared with cystic fibrosis (CF) patients known to be infected with the genetically identical strain of P. aeruginosa. Cross-infection with P. aeruginosa between CF patients and non-CF patients has not previously been described, and this finding raises significant issues relevant to the treatment of patients with non-CF suppurative lung disease.


* Corresponding author. Mailing address: Department of Respiratory Medicine, Royal Children's Hospital, Parkville 3052, Victoria, Australia. Phone: 61-3-9345 5818. Fax: 61-3-9349 1289. E-mail: philrob{at}rch.org.au.


Journal of Clinical Microbiology, December 2003, p. 5741, Vol. 41, No. 12
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.12.5741.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.